Figure 2From: Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer (a) Disease-free and (b) overall survival curves for tamoxifen-treated, hormone receptor positive breast cancer patients (n = 86) with respect to Fas ligand (FasL):Fas ratio. Survival was analyzed using the Kaplan–Meier method, and comparison of study groups was performed using the log-rank test.Back to article page